Home › Funds › Blue Owl Capital Holdings LP › CMPX
Blue Owl Capital Holdings LP position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Blue Owl Capital Holdings LP reported holding 619,700 shares of CMPX (COMPASS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$49K, representing 0.01% of its reported portfolio and ranking #49 among its reported holdings. Blue Owl Capital Holdings LP has disclosed CMPX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's CMPX position evolved
Blue Owl Capital Holdings LP first disclosed a stake in CMPX in Q4 2023 at 2,829,712 shares (US$4.4M). The position peaked in Q4 2025 at 3,466,525 shares, worth US$18.6M. Across 12 filings, Blue Owl Capital Holdings LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 619,700 shares valued at US$49K — an increase of 315,900 shares quarter over quarter.. Notable position changes include a 34% increase in Q4 2025 (shares fell 1% over the following quarter), a 88% trim in Q1 2026 (shares fell 59% over the following quarter), a 104% increase in Q3 2026 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 2.83M | $4.41M | New |
| Q1 2024 | 2.83M | $5.60M | Hold |
| Q2 2024 | 2.83M | $2.83M | Hold |
| Q3 2024 | 2.88M | $5.30M | Add |
| Q4 2024 | 2.95M | $4.28M | Add |
| Q1 2025 | 2.95M | $5.61M | Hold |
| Q2 2025 | 2.59M | $6.74M | Reduce |
| Q3 2025 | 2.59M | $9.07M | Hold |
| Q4 2025 | 3.47M | $18.62M | Add |
| Q1 2026 | 400.00K | $500.00K | Reduce |
| Q2 2026 | 303.80K | $106.33K | Reduce |
| Q3 2026 | 619.70K | $48.77K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CMPX and 13F data
CMPX (COMPASS THERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in CMPX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$39.4M), ORBIMED ADVISORS LLC (US$33.3M), MONTANOVA CAPITAL, LLC (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CMPX
- TANG CAPITAL MANAGEMENT LLC 17.99M sh · $39.40M · Q2 2026
- ORBIMED ADVISORS LLC 15.22M sh · $33.33M · Q2 2026
- MONTANOVA CAPITAL, LLC 14.10M sh · $30.88M · Q2 2026
- Enavate Sciences GP, LLC 7.79M sh · $17.06M · Q2 2026
- Palo Alto Investors LP 5.83M sh · $12.77M · Q2 2026
- Birchview Capital, LP 1.68M sh · $3.67M · Q2 2026
- Vivo Capital, LLC 3.42M sh · $3.56M · Q3 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held CMPX?
Blue Owl Capital Holdings LP has disclosed CMPX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Blue Owl Capital Holdings LP's current position in CMPX?
As of Q3 2026, Blue Owl Capital Holdings LP holds 619.70K shares of CMPX (COMPASS THERAPEUTICS INC), valued at $48.77K, representing 0.01% of its reported portfolio and ranking #49.
Has Blue Owl Capital Holdings LP been buying or selling CMPX?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP increased its position in CMPX. The position peaked in Q4 2025 at 3.47M shares.
Which other funds hold CMPX?
Other major institutional holders of CMPX include TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.